secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001493152-25-021567
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma closes $1.0M private placement of Series C Preferred Stock to Hexstone Capital
--------------------------------------------------------------------------------

- Hexstone purchased 100 Series C Preferred shares at $10,000 each plus a warrant for up to 9,900 additional shares; total cash $1,000,099.
- Series C Preferred convertible into common at the lesser of $5.00 fixed price or 85% of lowest trading price over a specified period.
- Board authorized up to 9,900 shares of Series C Preferred via Certificate of Designation filed November 4, 2025.
- Securities issued under private placement exemption per Section 4(a)(2) and Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/0001493152-25-021567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-021567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer